Equine Metabolic Syndrome (EMS) is a complex endocrine disorder characterized by obesity, insulin dysregulation (ID), and an increased risk of developing laminitis. Despite growing awareness of EMS, early and accurate diagnosis remains challenging. In this study, we investigated changes in the levels of circulating microRNAs (miRNAs) in plasma samples from horses diagnosed with EMS, compared to obese non-ID horses and healthy controls. Using a targeted real-time PCR OpenArray, we identified four miRNAs —miR-221, miR-186, miR-132, and miR-15a— that were differentially expressed across the groups. Functional enrichment analysis of their validated target genes revealed involvement in key insulin signalling mechanisms, including phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (AKT), AMP-activated protein kinase (AMPK) and forkhead box O protein (FOXO) signalling pathways. Receiver Operating Characteristic (ROC) curve analysis demonstrated that combinations of these miRNAs provided discriminatory power between clinical groups (AUCs ranging from 0.79 to 0.93). These findings support the potential of circulating miRNA levels as non-invasive predictive biomarkers for EMS and related metabolic dysfunctions. Moreover, the signalling pathways identified provide mechanistic insight and establish a foundation for future studies aimed at therapeutic target discovery.